Clinical trial reportBloodPublished
A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study
Regional connection
Verified Author affiliations on the Europe PMC record name Pennsylvania Hospital, University of Pennsylvania, with Penn Medicine linked by the institution reference. Affiliation source
- Institutions
- Penn Medicine, Pennsylvania Hospital, University of Pennsylvania
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Blood
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Piperidines; Pyrazoles; Pyrimidines; Adenine; Protein Kinase Inhibitors; Follow-Up Studies; Mutation; Aged; Aged, 80 and over; Middle Aged; Female
- PubMed ID
- 41405491
- PubMed Central ID
- PMC13077481
- Open access
- Yes, open
- Added to directory
- Source checked